echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Asia Pacific Pharmaceuticals Mosapride Citrate Granules Obtained Drug Registration Certificate

    Asia Pacific Pharmaceuticals Mosapride Citrate Granules Obtained Drug Registration Certificate

    • Last Update: 2021-11-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On November 4, Asia-Pacific Pharmaceuticals issued an announcement stating that the company had received the "Drug Registration Certificate" for the chemical mosapride citrate granules approved and issued by the National Medical Products Administration


    Mosapride Citrate Granules is a prokinetic agent of the digestive tract and a selective serotonin (5-HT4) receptor agonist.


    At present, there are only tablet, capsule and oral solution dosage forms in China.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.